Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gh Research Plc (NQ: GHRS ) 14.09 +0.56 (+4.14%) Streaming Delayed Price Updated: 4:00 PM EDT, May 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Gh Research Plc < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More September 18, 2023 Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next Via Benzinga Exposures Product Safety 4 Of The 6 Largest Psychedelic Compound-Based R & D Stocks Had A Good Week September 17, 2023 4 of the 6 psychedelic-compound-based research & development stocks in our Psychedelic Drug Stocks Index were up in price last week versus only 1 the previous week. The Index was up 2.4% for the week... Via Talk Markets Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More September 11, 2023 Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassification Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence 6 Largest Psychedelic Compound-Based R & D Stocks In Decline September 10, 2023 The 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were down 2.6%, on average, this week and are now only up 6.5% YTD. Via Talk Markets GH Research: Q1 Earnings Insights May 11, 2023 Via Benzinga 6 Largest Psychedelic Compound-Based R & D Stocks Up 4%, On Average, Last Week September 05, 2023 The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index were UP 3.9%, on average, last week and are now only UP 9.4% YTD. Via Talk Markets Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More September 05, 2023 Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Via Benzinga August Recap: Largest Psychedelic Compound-Based R & D Stocks Down 15% September 02, 2023 The 6 psychedelic compound-based research & development stocks in our Psychedelic Drug Stocks Index were down 15.0%, on average, in August and are now only up 5.3% YTD. Via Talk Markets Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More August 28, 2023 Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials Via Benzinga GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026 August 24, 2023 GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharma company developing novel mebufotenin (5-MeO-DMT) therapies for Treatment-Resistant Depression (TRD) and one of the highest trading... Via Benzinga GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates August 23, 2023 From GH Research PLC Via GlobeNewswire Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports August 21, 2023 Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds Via Benzinga Topics Cannabis Economy Exposures Cannabis Interest Rates Largest Psychedelic Compound-Based R&D Stocks Continue Downward Trend August 20, 2023 The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index were down an average of 6% last week and are now down 17.2% MTD. We take a look at them in... Via Talk Markets Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More August 14, 2023 First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published Via Benzinga So Far, August Isn't Kind To 4 Of 6 Constituents In Our Psychedelic Drug Stocks Index August 13, 2023 The 6 psychedelic compound-based research & development stocks in our munKNEE Psychedelic Drug Stocks Index are down an average of 11.9% so far in August but are still up YTD. Via Talk Markets Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More August 03, 2023 A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances... Via Benzinga July Summary: Largest Psychedelic Compound-Based R&D Stocks Up 16%, On Average July 30, 2023 All but 1 of the 6 largest psychedelic compound-based research & development stocks advanced in July and are ranked below as to their performances so far in July: Via Talk Markets Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial July 28, 2023 UK’s short-acting psychedelics developer Small Pharma (OTCQB: DMTTF) published its financial results for the fiscal first quarter ended May 31, 2023: Via Benzinga Largest Psychedelic Compound-Based Drug Stocks Up 14% MTD; Now Up 27% YTD July 23, 2023 The psychedelic compound-based drug research and development sector is UP 13.6% MTD and is now UP 26.6% YTD and this article analyzes the performance of the 6 largest stocks in the Psychedelic Drug... Via Talk Markets Psychedelic Compound-Based Drug Stocks Up 12% MTD; Now Up 25% YTD July 14, 2023 Our Psychedelic Drug Stocks Index is up 12.3% MTD and is now up 25.1% YTD. Via Talk Markets Psychedelic Stocks Jumped 10% Last Week July 09, 2023 The FDA released a positive draft guidance for developing psychedelic treatments and the 6 largest stocks in the Psychedelic Drug Stocks Index responded accordingly Via Talk Markets Upward Trend In Largest Psychedelic Compound-Based R&D Stocks Continues July 01, 2023 Our Psychedelic Drug Stocks Index, which consists of the 6 largest psychedelic compound-based research & development companies, was up 3.4% this week, up 7.1% in June, up 6.3% in May, and is now up... Via Talk Markets The 3 Best Psychedelic Stocks to Buy Now June 29, 2023 Psychedelic stocks promise to bring therapeutics to market that were taboo until recently and have huge upside. Via InvestorPlace Upward Trend In Major Psychedelic Compound-Based Research & Development Stocks Continue June 17, 2023 There are 6 constituents in our munKNEE Psychedelic Drug Stocks Index and 5 of them advanced this week and are now all up MTD. Via Talk Markets Major Psychedelic Compound-Based Research & Development Stocks: June Update June 10, 2023 Psychedelic Drug Stocks Index has been revamped with the removal of Cybin (CYBN) which has dropped below $100M in market capitalization leaving 6 constituents in the Index Via Talk Markets May Summary Of Largest Psychedelic Compound-Based Drug Stock Performances June 01, 2023 Only two of the seven largest psychedelic compound-based drug stocks tracked, advanced in May. Via Talk Markets Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More May 15, 2023 Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths... Via Benzinga Arlo Technologies, Array Technologies, AirSculpt Technologies And Other Big Stocks Moving Higher On Friday May 12, 2023 U.S. stocks traded slightly lower, with the Dow Jones dropping around 15 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer May 11, 2023 GH Research PLC (NASDAQ: GHRS), a Dublin-based clinical-stage biotech company reported financial results for the first quarter ended March 31, 2023. Via Benzinga GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights May 11, 2023 From GH Research PLC Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.